Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
Yussim
A
A
Department of Transplantation, Rabin Medical Center, Petach Tikva, Israel.
Shaharabani
E
E
Mor
E
E
Lustig
S
S
Bar-Nathan
N
N
Shmueli
D
D
Sobolev
V
V
Dorfman
B
B
Or
H
H
Shapira
Z
Z
D000293:Adolescent; D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D008875:Middle Aged; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus